The former group president of Orthofix International NV and principal founder of BREG, Inc., has accepted the position of Chairman to the Advisory Board of Aurora Spine, LLC. Brad Mason assumed his new responsibilities with the Carlsbad, California, company on October 25, 2012.
Brad Mason Joins Aurora Spine

While Mason was chairman and CEO of BREG, Inc., a sports medicine orthopedics company, the firm grossed nearly $100 million in sales. Before his retirement, Mason was group president for North America for Orthofix International NV, a $550 million publicly traded, multinational orthopedic device manufacturing company.
We are honored to have Brad Mason join Aurora Spine as he brings a unique perspective to our leadership team. His experience and insight are incredibly valuable as we work to further establish Aurora’s position in the orthopedic spine industry, ” said Trent Northcuff, CEO of Aurora Spine. “We look forward to drawing on the depth of his knowledge and business expertise as we launch our disruptive MIS technology in the first quarter of 2013.
Aurora Spine specializes in minimally-invasive (MIS) regenerative technologies.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.